ArticleBMC infectious diseases2026
Lipid profile dynamics and associated cardiovascular disease risk indices in Chinese people living with human immunodeficiency virus receiving antiretroviral therapy.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundDyslipidemia is one of the leading contributing factors to HIV-related cardiovascular disease (CVD). In China, data regarding the dynamic changes in lipid profiles and dyslipidemia among people living with HIV (PLWH) receiving long-term antiretroviral therapy (ART) remain scarce, especially in Jiangxi Province. Therefore, this study aimed to longitudinally analyze the changes in lipid profiles and dyslipidemia among PLWH in Nanchang City and evaluated composite metabolic indices to assess the future CVD risk.
methodsDemographic data and clinical parameters were collected. The risk factors and longitudinal changes in lipid profiles and composite metabolic indices associated with HIV infection and ART were analyzed using mixed-effects models and generalized estimating equations. The definition of dyslipidemia was made based on the Chinese Guidelines for Lipid Management (2023).
resultsThe study included 417 participants of whom 356 were male. Their mean age at baseline was 46.90 ± 15.84 years. The overall prevalence of dyslipidemia was 58.51% at enrollment and rose to 73.62% after 5 years of ART, with high TG and high TC as the most common abnormalities. Across all ART regimens, the proportion of patients with abnormally elevated TG and TC levels increased significantly over time after ART initiation (all P < 0.05). The lopinavir/ritonavir (LPV/r) + lamivudine (3TC) + zidovudine (AZT) regimen exhibited the most pronounced associations with increased risks of these lipid abnormalities. The proportion of individuals with severe elevations in atherogenic index of plasma (AIP) and those in the 4th quartile of the triglyceride-glucose (TyG) index increased significantly over the follow-up period (both P < 0.05).
conclusionsThe prevalence of dyslipidemia was notably high in PLWH receiving ART in Jiangxi Province, with the lipid profiles of most patients exhibiting significant changes within the first 3 months of ART initiation. This finding highlights the importance of implementing early lipid monitoring and selecting lipid-friendly ART regimens for this population. Furthermore, the AIP and the TyG index should be advocated for use starting from the initiation of ART to dynamically assess and stratify CVD risk during follow-up.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.